Novel serine protease inhibitors. - Wikidata - awgldk - TriplyDB

Novel serine protease inhibitors.

Novel serine protease inhibitors.

http://www.wikidata.org/entity/Q38162937

about

Novel serine protease inhibitors.

http://www.wikidata.org/entity/Q38162937

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel serine protease inhibitors.

@en

type

label

Novel serine protease inhibitors.

@en

prefLabel

Novel serine protease inhibitors.

@en

P1433

Q38162937-66A8DC2D-206F-4565-9B48-F934CF8CA913

P1476

Q38162937-649DEAB7-A929-4CA6-8B3E-3EA57286EC93

P2093

Q38162937-31B32BD5-73DE-448D-B504-7BB8A8AB1797

Q38162937-8D671B1E-66AA-4753-BD67-63781638B109

P2860

Q38162937-0B63675F-15F6-486C-811A-B232B83F3528

Q38162937-15672CFD-BB17-4B7F-816B-A0DEF85102FF

Q38162937-19AF3CC0-6734-4186-A94E-B815F83A55F1

Q38162937-2776D1B0-701E-4ADC-A270-D21E95D86CB8

Q38162937-3AC3E587-3D76-4733-9E1D-EF33AE61558C

Q38162937-4A12E71A-0F15-4A41-AEAA-2B2818F67504

Q38162937-4C15A39D-B611-437A-80CA-00D995AD9103

Q38162937-528E193D-24C4-4817-8343-927A4B591CF3

Q38162937-53F2C437-7F05-4B60-A1C4-0BF961E138B0

Q38162937-5494940A-1D57-454C-B0A5-D1238ED8F081

P304

Q38162937-9E84C78D-7D74-4661-BA4F-DEDC1D2024EC

P31

Q38162937-3FC53920-C434-456A-A303-0F178A311B29

P356

Q38162937-6241FED8-83BA-4261-9458-10797D74ADFE

P433

Q38162937-9D25D669-2F0B-4877-BB85-CC192CC393E3

P478

Q38162937-B88F3E08-187D-47BA-ACB4-B14C6D9AD059

P577

Q38162937-D0653289-6931-4A9F-A5C6-019526D6E745

P698

Q38162937-73093533-D910-4178-8037-21F8A2771FF7

P356

P1433

Pharmaceutical patent analyst

P1476

Novel serine protease inhibitors.

@en

P2093

Anilkumar R Kore

http://www.w3.org/2001/XMLSchema#string

Muthian Shanmugasundaram

http://www.w3.org/2001/XMLSchema#string

P2860

Boceprevir for previously treated chronic HCV genotype 1 infection

In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor

Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form

Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulat

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

Genetic organization and diversity of the hepatitis C virus

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Advances in the development of thrombin inhibitors

Clinical aspects of platelet inhibitors and thrombus formation

Irreversible inhibitors of serine, cysteine, and threonine proteases

P304

457-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/PPA.12.49

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24236883

http://www.w3.org/2001/XMLSchema#string